The effect of a hemostatic agent (fastact) to wound and tissue repair in a rat model
Amaç: Bu çalışmanın amacı, in vivo olarak hemostatik bir ajanın (FastAct) prilokain hidroklorid ile beraber veya onsuz, yara ve doku iyileşmesini kolaylaştırdığı hipotezinin test edilmesidir. Yara iyileşmesi kanama ve hemostaz ile başlayan kompleks bir prosedürdür. Sığır protein faktörleri II, VII, IX ve X'u ihtiva eden FastAct pıhtı oluşumunda faktör II, V, VIII ve XIII'ü aktive etmesi için katalizör olarak kullanılır. Gereçler ve Yöntemler: Çalışma 21 erkek Wistar rat üzerinde gerçekleştirildi. Tüm hayvanların sırtında 4 cm'lik kutanöz insizyonlar yapıldı. Yedi hayvanda yara kenarları arasına sadece FastAct uygulanırken, diğer yedisinde FastAct prilokain ile birlikte uygulandı. Yara dudakları rezorbe olan sutur materyali ile kapatıldı. Bulgular: Örnekler yedinci gün elde edildi. Histolojik inceleme öncesinde örneklere germe ve çekme testleri uygulandı. FastAct grubunda epitelizasyon ve yara iyileşmesinin diğer gruba göre daha iyi olduğu tespit edildi. Germe ve çekme testlerinde FastAct grubu sonuçlarının daha iyi olduğu gözlendi. Sonuç: FastAct'in hemostazisi sağladığı, doğal süreçler yardımıyla yara iyileşmesini kolaylaştırdığı sonucuna ulaşılmıştır.
Bir hemostatik ajanin (fastact) deneysel rat modelinde yara ve doku iyileşmesi üzerine etkisi
Objectives: The purpose of this study was to test the hypothesis that the hemostatic agent (FastAct) exerts favourable effect on wound healing and tissue repair alone and along with prilocaine hydrochloride in vivo. Wound healing process is a complex procedure that starts with bleeding and hemostasis. Comprising of bovine factor proteins II, VII, IX and X, FastAct is used as a catalyst in the clot formation process to activate factors II, V, VIII and XIII. Materials and Methods: The study was performed on 21 Wistar male rats. Cutaneous incisions at the length of 4 cm. were made on the dorsal side of all animals. In seven, FastAct was applied alone between the wound edges and, in the other seven, FastAct was applied along with prilocaine. The wounds were sutured by resorbable suture material. Results: The specimens were obtained on the seventh day. Wound breaking strength test was performed before histological examination. In the FastAct group the epithelialization and the closure of the wound edge were better than the other groups. The results of the breaking strength test showed that the results were best in FastAct group. Conclusion: It's concluded that FastAct accomplished hemostasis, facilitated wound healing in accordance with natural processes.
___
- 1) Schonauer C, Tessitore E, Barbagallo G, Albanese V, Moraci A. The use of local agents: bone wax, gelatin, collagen, oxidized cellulose. Eur Spine J 2004;13 Suppl 1:S89-96.
- 2) Malmquist JP, Clemens SC, Oien HJ, Wilson SL. Hemostasis of oral surgery wounds with the HemCon Dental Dressing. J Oral Maxillofac Surg 2008;66:1177-83.
- 3) Soares LP, Oliveira MG, Pinheiro AL, Fronza BR, Maciel ME. Effects of laser therapy on experimental wound healing using oxidized regenerated cellulose hemostat. Photomed Laser Surg 2008;26:10-3.
- 4) FastAct product catalogue. Available from: http://www. toplibra.co.il/catalogMain.asp?cat_id=6&id=24.
- 5) He Y, Chang G, Zhan S, Song X, Wang X, Luo Y. Soluble tissue factor has unique angiogenic activities that selectively promote migration and differentiation but not proliferation of endothelial cells. Biochem Biophys Res Commun 2008;370:489-94.
- 6) Kroez M, Lang W, Dickneite G. Wound healing and degradation of the fibrin sealant Beriplast P following partial liver resection in rabbits. Wound Repair Regen 2005;13:318-23.
- 7) Pietramaggiori G, Yang HJ, Scherer SS, Kaipainen A, Chan RK, Alperovich M, et al. Effects of poly-N-acetyl glucosamine (pGlcNAc) patch on wound healing in db/db mouse. J Trauma 2008;64:803-8.
- 8) Padovan LE, Okamoto T, Rezende MC, Curvêllo VP, Nicolielo D, Matsumoto MA. Fibrin adhesive implant in wound healing repair of dental sockets with topical application of epsilon aminocaproic acid: histological analysis. J Biomed Mater Res B Appl Biomater 2005;73:209-13.
- 9) Dinehart SM. Topical, local, and regional anesthesia. In: Wheeland RG, editor. Cutaneous surgery. 1st ed. Philadelphia: WB Saunders; 1994. p. 102-12.
- 10) Doğan N, Uçok C, Korkmaz C, Uçok O, Karasu HA. The effects of articaine hydrochloride on wound healing: an experimental study. J Oral Maxillofac Surg 2003;61:1467-70.
- 11) Morin RJ, Tomaselli NL. Interactive dressings and topical agents. Clin Plast Surg 2007;34:643-58.
- 12) Wound Healing. Available from: http://www.vitacost. com/Healthnotes/Concern/Wound-Healing.aspx
- 13) Shetty V, Bertolami C. The physiology of wound healing. In: Peterson LJ, editor. Principles of oral and maxillofacial surgery. 3rd ed. Philadelphia: Lippincott; 1992. p. 3-18.
- 14) Morris T, Tracey J. Lignocaine: its effects on wound healing. Br J Surg 1977;64:902-3.
- 15) Eriksson AS, Sinclair R, Cassuto J, Thomsen P. Influence of lidocaine on leukocyte function in the surgical wound. Anesthesiology 1992;77:74-8.
- 16) Drucker M, Cardenas E, Arizti P, Valenzuela A, Gamboa A. Experimental studies on the effect of lidocaine on wound healing. World J Surg 1998;22:394-7.
- 17) Eroglu E, Eroglu F, Agalar F, Altuntas I, Sutcu R, Ozbasar D. The effect of lidocaine/prilocaine cream on an experimental wound healing model. Eur J Emerg Med 2001;8:199-201.
- 18) Smith GA, Strausbaugh SD, Harbeck-Weber C, Cohen DM, Shields BJ, Powers JD. Prilocaine-phenylephrine topical anesthesia for repair of mucous membrane lacerations. Pediatr Emerg Care 1998;14:324-8.
- 19) Nykanen D, Kissoon N, Rieder M, Armstrong R. Comparison of a topical mixture of lidocaine and prilocaine (EMLA) versus 1% lidocaine infiltration on wound healing. Pediatr Emerg Care 1991;7:15-7.